SEMA

SEMA refers to Semaglutide, a synthetic peptide analog of the GLP-1 (glucagon-like peptide-1) hormone that has been widely studied in metabolic and endocrine research. It is primarily known for its role in glucose regulation and appetite signaling pathways.

What it is
Semaglutide is a long-acting GLP-1 receptor agonist designed to mimic the body’s natural incretin hormones, which help regulate blood sugar levels and energy balance.

Commonly studied uses / potential benefits
In research settings, SEMA is commonly associated with studies on:

• Blood glucose regulation and insulin response
• Appetite suppression and satiety signaling
• Body weight management mechanisms
• Metabolic health and energy balance pathways

Potential side effects / precautions (research context)
Observed or discussed effects in studies may include:

• Nausea or gastrointestinal discomfort
• Reduced appetite
• Fatigue or mild dizziness
• Possible digestive changes